Fredun Pharmaceuticals board approves 2:1 bonus issue

Fredun Pharmaceuticals has announced a 2:1 bonus issue where the company will pay two fully paid-up equity shares of Rs ...

Rigel Pharmaceuticals (RIGL) Set to Report Q4 FY2025 Earnings After the Bell — Here’s What to Expect

by theadvisertimes.com

March 3, 2026

0

Consensus Estimates Metric Q4 FY2025 Estimate Q4 FY2024 Actual YoY Change Revenue ~$75–85M ~$57.6M +30-48% EPS ~$1.60–1.80 ~$0.8 Significant expansion ...

Teva Pharmaceuticals – TEVA: Abschied vom Generika-Geschäft! Was nun?

by theadvisertimes.com

February 13, 2026

0

Strategische Neuausrichtung! Pullback-Setup bei der Teva-Aktie! Kommt der Bounce nach 7 roten Kerzen? Quartalszahlen erst im Mai! Teva Pharmaceuticals (TEVA) ...

Here’s What Lifted Vertex Pharmaceuticals (VRTX) in Q4

by theadvisertimes.com

January 12, 2026

0

ClearBridge Investments, an investment management company, released its “ClearBridge Growth Strategy” fourth-quarter 2025 investor letter. A copy of the letter can ...